EFG
ALNY icon

Everhart Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Everhart Financial Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$797K Sell
2,646
-255
-9% -$76.9K 0.05% 213
2026
Q1 		$960K Buy
2,901
+360
+14% +$123K 0.08% 182
2025
Q4 		$1.01M Sell
2,541
-89
-3% -$39.4K 0.09% 153
2025
Q3 		$1.2M Buy
2,630
+437
+20% +$178K 0.12% 114
2025
Q2 		$715K Buy
2,193
+406
+23% +$112K 0.08% 179
2025
Q1 		$483K Buy
1,787
+191
+12% +$49.1K 0.07% 212
2024
Q4 		$376K Sell
1,596
-110
-6% -$28.9K 0.08% 231
2024
Q3 		$469K Buy
1,706
+384
+29% +$100K 0.1% 201
2024
Q2 		$321K Buy
+1,322
New +$209K 0.08% 217

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Everhart Financial Group's ALNY Position: Q2 2026 in Review

Everhart Financial Group reduced its Alnylam Pharmaceuticals (ALNY) stake by 8.8% in Q2 2026, selling an estimated $76.9K and leaving 2,646 shares worth $797K. The position accounts for 0.05% of the portfolio, ranked #213.

Everhart Financial Group first reported a position in ALNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.2M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Everhart Financial Group held 2,646 shares of Alnylam Pharmaceuticals worth $797K as of Q2 2026.
  • Everhart Financial Group sold 255 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $76.9K.
  • Alnylam Pharmaceuticals made up 0.05% of Everhart Financial Group's portfolio in Q2 2026, its #213 holding.
  • Everhart Financial Group first reported a position in Alnylam Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Everhart Financial Group's Alnylam Pharmaceuticals position peaked at $1.2M in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.